Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

T-Bank to issue additional shares to convert Rosbank's shares

10/2/24 T

Shareholders of EvroTrans approved dividends

10/2/24 EUTR

Magnit will open stores in the Magadan region

10/2/24 MGNT

TGC-14 invests about ₽40 billion in modernization of CHPP-2 in Ulan-Ude

10/2/24 TGKN

Shareholders of NOVATEK approved dividends

10/2/24 NVTK

TGC-14 set the SPO price

10/2/24 TGKN

Softline completes placement of additional share issue

10/2/24 SOFL

X5 Retail Group buys May24 marketplace

10/2/24 X5

Shareholders of Gazprom Neft approved dividends

10/1/24 SIBN

Shareholders of Udmurtneft approved dividends

10/1/24 UDMN